In this context, the study of the Nrf2/Keap1 pathway is particularly relevant, given the high prevalence of NAFLD in the general population, and in particular in those affected by type 2 diabetes and obesity (approximately 30%) [25]. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatotic liver disease.